Investors have been souring on Lemonade (NASDAQ: NYSE:LMND) for the past several months after the stock price peaked in early January. There have been a multitude of reasons for the decline including broad reasons like investors rotating
Lemonade: A Very High Upside Insurance Investment
Summary
- Lemonade has been showing very strong fundamental growth, while also showing a nascent ability to diversify its business across numerous insurance products.
- Investors have been disappointed recently that there is no firm date for the debut of Lemonade Car insurance.
- Lemonade is stepping down their reinsurance quota share from 75% to 70%, as they also complete a favorable reinsurance renewal.
- The company is a buy at current prices for aggressive investors willing to speculate in a very high upside, speculative stock.
I have been a Merchant Seaman that has traveled the world for over 30 years. Within the last 15 years, I developed a very intense interest in investing. I learned a lot of what I know about investing from The MF. Also because I have a engineering background, I often tend to gravitate to Tech stocks
Analyst’s Disclosure:I/we have a beneficial long position in the shares of LMND either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.